6.4. Summary of evidence and recommendation for the prognosis of UTUC. Summary of evidenceLEImportant prognostic factors for risk stratification include tumour size, stage, grade, multifocality, hydronephrosis and different histological subtypes.3Models are available to predict pT2/non-organ confined disease and prognosis after RNU.3Patient, tumour, and treatment-related factors impact risk of bladder recurrence after both kidney-sparing management and RNU.3Currently, no molecular biomarkers are validated for clinical use.3 RecommendationStrength ratingUse prognostic factors to risk-stratify patients for therapeutic guidance.Strong 